Cargando…
Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia
With the treatment advances over the last three decades, acute promyelocytic leukemia (APL) has evolved from being the most malignant form of acute leukemia to a leukemia with excellent long term survival rates. In the present review, we have summarized data leading to the development of the current...
Autores principales: | Kulkarni, Uday, Mathews, Vikram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947681/ https://www.ncbi.nlm.nih.gov/pubmed/33718181 http://dx.doi.org/10.3389/fonc.2021.621566 |
Ejemplares similares
-
Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
por: Masetti, Riccardo, et al.
Publicado: (2023) -
Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse
por: Kulkarni, Uday Prakash, et al.
Publicado: (2023) -
Editorial: Acute Promyelocytic Leukemia — Towards A Chemotherapy-Free Approach to Cure in All Patients
por: Gill, Harinder, et al.
Publicado: (2022) -
The History of the Chemo-Free Model in the Treatment of Acute Promyelocytic Leukemia
por: Zhu, Hong-Hu
Publicado: (2020) -
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome
por: LaBella, Dominic, et al.
Publicado: (2022)